Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-DUAL TICLO PCI
2024-518666-27-00Phase 4Completed
- Sponsor
- Zuyderland
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute coronary syndrome (ACS), Atrial fibrillation (AFib) and coronary arteriosclerosis comparing dabigatran + ticagrelor with dabigatran + clopidogrel (2 arms). Started Nov 2024; status: completed.
02
Drugs
dabigatranticagrelorclopidogrel
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on 2024-518666-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518666-27-00.